13F 机构持仓
中文EN

COSM Cosmos Health Inc.

Wholesale-Drugs, Proprietaries & Druggists' Sundries · Nasdaq · SEC CIK 1474167 · 财年截止 12 月 31 日

财务因子 截至 2026-06-30(2026Q2),TTM = 最近四个季度合计

成长

TTM 营收同比33.8%
TTM 净利同比-13.1%
TTM EPS 同比35.6%
营收 3 年复合增长14.8%
净利 3 年复合增长—

利润率

毛利率10.3%
营业利润率-24.9%
净利率-33.1%
自由现金流利润率-13.5%
EBITDA 利润率-23.0%

回报

ROE-104.0%
ROA-39.6%
ROIC(近似)-54.8%
资产周转率1.20x

杠杆与偿债

资产负债率66.4%
债务权益比0.15x
流动比率1.05x
利息覆盖倍数-7.80x

现金质量与分红

经营现金流 / 净利0.40x
应计比率-23.6%
派息率—
资本开支 / 营收0.1%

专业版可看因子的历史走势图和全部历史财报 🔒

财务报表

科目 2026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-312024Q32024-09-30
利润表
营业收入$1,898.64万$1,792.79万$1,970.32万$1,711.04万$1,474.57万$1,371.25万$1,422.42万$1,241.10万
营业成本$1,747.47万$1,654.67万$1,762.38万$1,450.78万$1,358.19万$1,166.27万$1,322.06万$1,120.42万
毛利$151.17万$138.12万$207.93万$260.26万$116.38万$204.98万$100.36万$120.69万
研发费用$6.86万$0$41.08万$1.83万$7.46万$1.56万$53.33万$0
销售及管理费用$206.61万$180.02万$1,060.96万$204.03万$149.05万$147.87万$714.16万$178.30万
营业利润-$292.56万-$218.42万-$1,140.64万-$181.87万-$264.53万-$83.31万-$896.68万-$223.99万
利息费用$60.24万$42.32万$65.48万$66.92万$38.88万$18.71万$31.98万$18.14万
税前利润-$608.65万-$280.54万-$1,014.59万-$535.29万-$282.81万-$81.81万-$954.31万-$218.25万
所得税$0$0$0$0$0$0$0$0
归母净利润-$608.65万-$280.54万-$1,014.59万-$535.29万-$282.81万-$81.81万-$954.31万-$837.76万
EBITDA-$257.64万-$183.77万-$1,109.13万-$144.08万-$229.15万-$51.73万-$866.20万-$193.57万
基本每股收益-0.10-0.06—-0.17-0.10-0.03—-0.45
稀释每股收益-0.10-0.06—-0.17-0.10-0.03—-0.45
加权平均股数(稀释)5,992.32万4,708.76万—3,062.53万2,875.35万2,603.76万—1,841.83万
资产负债表
现金及等价物$180.09万$51.47万$71.57万$88.94万$65.55万$74.29万$31.51万$331.48万
短期投资$3.75万$3.42万$4.62万$3.32万$3.03万$2.53万$2.11万$2.28万
应收账款$1,886.08万$1,818.66万$1,962.88万$1,802.95万$1,545.58万$1,425.19万$1,347.83万$1,748.42万
存货$451.86万$565.05万$577.81万$568.37万$511.09万$473.62万$435.54万$488.50万
流动资产$3,666.87万$3,688.93万$3,838.83万$3,810.43万$3,056.23万$2,784.50万$2,546.13万$3,623.89万
固定资产净额$1,014.01万$1,028.02万$1,057.89万$1,066.48万$1,082.04万$1,001.61万$968.95万$1,057.59万
商誉$4.97万$4.97万$4.97万$4.97万$4.97万$4.97万$4.97万$4.97万
无形资产$691.62万$717.53万$752.00万$791.09万$817.57万$775.28万$770.68万$769.71万
总资产$6,146.20万$6,236.90万$6,547.75万$6,949.28万$6,183.56万$5,719.19万$5,431.19万$6,452.00万
流动负债$3,484.27万$3,407.68万$3,827.18万$3,853.43万$3,116.66万$2,658.60万$2,575.75万$2,521.12万
长期债务$319.49万$345.06万$377.53万$536.59万$519.05万$485.23万$410.89万$426.80万
总债务$319.49万$345.06万$377.53万$536.59万$519.05万$485.23万$410.89万$426.80万
总负债$4,078.75万$4,254.27万$4,705.29万$4,635.79万$3,560.39万$3,124.02万$2,977.90万$2,954.34万
归母股东权益$2,067.45万$1,982.64万$1,842.46万$2,313.49万$2,623.16万$2,595.17万$2,453.29万$3,497.66万
净债务$139.39万$293.59万$305.97万$447.64万$453.50万$410.94万$379.38万$95.31万
期末流通股数8,067.12万4,106.73万4,106.73万3,186.90万2,971.78万2,719.81万2,360.26万2,325.95万
现金流量表
经营活动现金流-$171.83万-$106.71万-$459.63万-$245.50万-$120.99万-$18.63万-$383.38万$73.98万
资本开支$6.36万$1.14万$7,895$1.27万$2.25万$1.25万$7.25万$22.88万
自由现金流-$178.19万-$107.85万-$460.42万-$246.78万-$123.25万-$19.88万-$390.63万$51.10万
投资活动现金流$11.46万-$70.90万-$106.96万-$101.00万$7.18万-$7,069-$100.52万-$3.54万
筹资活动现金流$178.87万$34.76万$469.87万$719.22万$160.44万$56.09万$162.01万$268.00万
折旧摊销$34.92万$34.65万$31.51万$37.79万$35.39万$31.58万$30.49万$30.41万
股权激励费用$55.89万$53.58万$58.20万$0$0$55.66万$58.65万$0
股票回购——————$0—

免费方案显示最近 8 期,专业版可看全部 68 期 🔒

· 大多数公司不单独披露第四季度:Q4 = 全年 − 前三季累计(标 *),每股收益和股数不能相减,所以 Q4 的 EPS 常为空;现金流量表在季报里只报年初至今累计,单季多为推算。

· 不提供市盈率、市净率等依赖股价的指标(本站不使用授权行情)。空白显示为 —。

数据来源:SEC EDGAR XBRL(公司向 SEC 提交的财报),更新于 2026-11-18 06:30。